Terms: = Sarcomas AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
26 results:
1. cxcr4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.
Hartlapp I; Hartrampf PE; Serfling SE; Wild V; Weich A; Rasche L; Roth S; Rosenwald A; Mihatsch PW; Hendricks A; Wiegering A; Wiegering V; Hänscheid H; Schirbel A; Werner RA; Buck AK; Wester HJ; Einsele H; Kunzmann V; Lapa C; Kortüm KM
J Nucl Med; 2023 Sep; 64(9):1424-1430. PubMed ID: 37348915
[TBL] [Abstract] [Full Text] [Related]
2. Development of
Trujillo-Nolasco M; Cruz-Nova P; Ferro-Flores G; Gibbens-Bandala B; Morales-Avila E; Aranda-Lara L; Vargas M; Ocampo-García B
J Biomed Nanotechnol; 2021 Feb; 17(2):263-278. PubMed ID: 33785097
[TBL] [Abstract] [Full Text] [Related]
3. Cytotoxic drugs in combination with the cxcr4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
[TBL] [Abstract] [Full Text] [Related]
4. Expression of cxcr4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Significance of Cancer Stem Cell Markers CD133 and cxcr4 in Osteosarcomas.
Mardani A; Gheytanchi E; Mousavie SH; Madjd Jabari Z; Shooshtarizadeh T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):67-73. PubMed ID: 31983166
[TBL] [Abstract] [Full Text] [Related]
6. CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma.
Tang Y; Gu Z; Fu Y; Wang J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696204
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.
Kawamoto K; Miyoshi H; Yoshida N; Takizawa J; Sone H; Ohshima K
Am J Surg Pathol; 2016 Nov; 40(11):1473-1483. PubMed ID: 27631510
[TBL] [Abstract] [Full Text] [Related]
8. High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis.
Wu J; Long Z; Cai H; Du C; Liu X; Yu S; Wang Y
Oncotarget; 2016 Aug; 7(31):49834-49847. PubMed ID: 27409174
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and prognostic significance of chemokine receptor cxcr4 in patients with bone and soft tissue sarcoma: a meta-analysis.
Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
[TBL] [Abstract] [Full Text] [Related]
10. Identification and analysis of cxcr4-positive synovial sarcoma-initiating cells.
Kimura T; Wang L; Tabu K; Tsuda M; Tanino M; Maekawa A; Nishihara H; Hiraga H; Taga T; Oda Y; Tanaka S
Oncogene; 2016 Jul; 35(30):3932-43. PubMed ID: 26640147
[TBL] [Abstract] [Full Text] [Related]
11. Coexpression of cxcr4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract] [Full Text] [Related]
12. CXCL14, CXCR7 expression and cxcr4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
[TBL] [Abstract] [Full Text] [Related]
13. cxcr4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation.
Roccaro AM; Mishima Y; Sacco A; Moschetta M; Tai YT; Shi J; Zhang Y; Reagan MR; Huynh D; Kawano Y; Sahin I; Chiarini M; Manier S; Cea M; Aljawai Y; Glavey S; Morgan E; Pan C; Michor F; Cardarelli P; Kuhne M; Ghobrial IM
Cell Rep; 2015 Jul; 12(4):622-35. PubMed ID: 26190113
[TBL] [Abstract] [Full Text] [Related]
14. AMD3100 reduces cxcr4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
[TBL] [Abstract] [Full Text] [Related]
15. Close correlation between cxcr4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
[TBL] [Abstract] [Full Text] [Related]
16. The role of the CXCL12-cxcr4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).
Liao YX; Zhou CH; Zeng H; Zuo DQ; Wang ZY; Yin F; Hua YQ; Cai ZD
Int J Mol Med; 2013 Dec; 32(6):1239-46. PubMed ID: 24127013
[TBL] [Abstract] [Full Text] [Related]
17. IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells.
Wang M; Wang L; Ren T; Xu L; Wen Z
Cancer Biol Ther; 2013 Feb; 14(2):155-63. PubMed ID: 23192273
[TBL] [Abstract] [Full Text] [Related]
18. Wnt5a promotes ewing sarcoma cell migration through upregulating cxcr4 expression.
Jin Z; Zhao C; Han X; Han Y
BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
[TBL] [Abstract] [Full Text] [Related]
19. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
Kwon JE; Jung WH; Koo JS
Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
[TBL] [Abstract] [Full Text] [Related]
20. Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma.
Baumhoer D; Smida J; Zillmer S; Rosemann M; Atkinson MJ; Nelson PJ; Jundt G; von Luettichau I; Nathrath M
Mod Pathol; 2012 Apr; 25(4):522-8. PubMed ID: 22173290
[TBL] [Abstract] [Full Text] [Related]
[Next]
